A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

The Phase 1 GALLOP study evaluating the investigational CAR-T therapy, CB-010, for treatment of lupus nephritis has launched.

A new study published in JAMA Dermatology reveals that people with cutaneous lupus are 72 per cent more likely to develop ...

Nick Cannon opened up about his lupus diagnosis during a new house tour of his ‘Cannon Estate,’ comparing his lupus journey ...

Results showed that systemic lupus carries the greatest risk for heart health, more than doubling a person’s risk of heart disease compared to the healthy control group. But cutaneous lupus also ...

A new study investigates the role of Krüppel-like factor 2 (KLF2, a protein coding gene involved in a variety of regulatory ...

Increased odds of atherosclerotic cardiovascular disease seen in association with CLE and SLE, but not psoriasis.

New research reveals how social determinants of health significantly affect lupus treatment outcomes in Black patients, with ...

Prophylactic valaciclovir was effective and prevented herpes zoster in patients with systemic lupus erythematosus receiving ...

Controlling cardiovascular risk factors and maintaining long-term disease remission mitigated the increased risk for ...

Patients with cutaneous lupus erythematosus may be at an increased risk for atherosclerotic cardiovascular disease, even more ...